# Mammea siamensis Flower Extract-Induced Cell Death Apoptosis in HCT116 Colon Cancer Cells via Vacuolar-Type H+-ATPase Inhibition Associated with GSK-3β/β-Catenin, PI3K/Akt/NF-κB, and MAPK Signaling Pathway

**Authors:** Pornnapa Sitthisuk, Watcharaporn Poorahong, Sukanda Innajak, Aungkana Krajarng, Siritron Samosorn, Ramida Watanapokasin

PMC · DOI: 10.3390/ph18040441 · Pharmaceuticals · 2025-03-21

## TL;DR

This study shows that an extract from the Mammea siamensis flower can kill colon cancer cells by triggering apoptosis through several key signaling pathways.

## Contribution

The novel finding is that MS extract induces apoptosis via V-ATPase inhibition and modulation of multiple signaling pathways in colon cancer cells.

## Key findings

- MS extract increased cytotoxicity and induced apoptosis in HCT116 colon cancer cells.
- The extract activated caspase activity and modulated pro- and anti-apoptotic proteins.
- MS extract inhibited V-ATPase and modulated key signaling pathways like GSK-3β/β-catenin and PI3K/Akt/NF-κB.

## Abstract

Background and Objective: Mammea siamensis (MS) is a Thai herb used in traditional medicine. Previous studies have reported the antiproliferative effects of its constituents in various cancer cell lines. However, the effects of MS extract on cytotoxicity and molecular mechanisms of apoptosis induction in HCT116 colon cancer cells have not been fully explored. Methods and Results: The cytotoxic effect of MS extract on HCT116 cells was assessed using the MTT assay. MS extract increased cytotoxicity in a concentration-dependent manner. It also induced nuclear morphological changes and disrupted the mitochondrial membrane potential (ΔΨm), as assessed by Hoechst 33342 and JC-1 staining, respectively. These findings indicated that MS extract induced apoptosis, which was further confirmed by flow cytometry showing an increase in the sub-G1 phase. To investigate the expression of signaling proteins, Western blot analysis was conducted. The results showed that MS extract activated caspase activity (caspase-8, -9, and -7) and inhibited PARP activity. Additionally, MS extract upregulated pro-apoptotic proteins (tBid, Bak, and cytochrome c) while downregulating anti-apoptotic proteins (Bcl-2 and Bcl-xL). Mechanistic studies revealed that MS extract activated MAPK pathways while inactivating the PI3K/Akt/NF-κB and GSK-3β/β-catenin pathways. Notably, MS extract also inhibited V-ATPases, as evaluated by acridine orange staining and Western blot analysis. Conclusions: Our findings suggest that MS extract induces apoptosis via the activation of both intrinsic and extrinsic pathways associated with the key signaling pathways. Therefore, MS extract shows potential as a therapeutic agent for colon cancer.

## Linked entities

- **Genes:** GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], ctnnb1.S (catenin beta 1 S homeolog) [NCBI Gene 380441], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], MAPK (mitogen activated kinase-like protein) [NCBI Gene 7446652], PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142], BAK1 (BCL2 antagonist/killer 1) [NCBI Gene 578], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], Bcl2l1 (BCL2-like 1) [NCBI Gene 12048]
- **Proteins:** casp8 (caspase 8, apoptosis-related cysteine peptidase), Casp9 (caspase 9), Casp7 (caspase 7), Cyt-c-d (Cytochrome c distal)
- **Diseases:** colon cancer (MONDO:0002032)

## Full-text entities

- **Genes:** BCL2L1 (BCL2 like 1) [NCBI Gene 598] {aka BCL-XL/S, BCL2L, BCLX, Bcl-X, PPP1R52}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, COL11A2 (collagen type XI alpha 2 chain) [NCBI Gene 1302] {aka DFNA13, DFNB53, FBCG2, HKE5, OSMEDA, OSMEDB}, BAK1 (BCL2 antagonist/killer 1) [NCBI Gene 578] {aka BAK, BAK-LIKE, BCL2L7, CDN1}, GSK3B (glycogen synthase kinase 3 beta) [NCBI Gene 2932], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** MS (MESH:D014012), cancer (MESH:D009369), Colon Cancer (MESH:D015179), cytotoxicity (MESH:D064420)
- **Cell lines:** HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12030214/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12030214/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC12030214/full.md

---
Source: https://tomesphere.com/paper/PMC12030214